Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001708138-22-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-16 | 2022-02-15 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $629.34 | -3,540 | 61.9K | -5% | -$2.23M |
| D | 2022-02-16 | 2022-02-14 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $179.13 | +10.0K | 68.5K | +17% | +$1.79M |
| D | 2022-02-16 | 2022-02-14 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $626.79 | -6,460 | 62.0K | -9% | -$4.05M |
| D | 2022-02-16 | 2022-02-14 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -10.0K | 30.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | S | D | 421 | $626.51 | 61,440 | D | — | — | (F3) Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-02-15 | S | D | 630 | $627.49 | 60,810 | D | — | — | (F4) Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-02-15 | S | D | 520 | $628.62 | 60,290 | D | — | — | (F5) Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 4 | Common | Common Stock | 2022-02-15 | S | D | 533 | $629.35 | 59,757 | D | — | — | (F6) Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 5 | Common | Common Stock | 2022-02-15 | S | D | 434 | $630.41 | 59,323 | D | — | — | (F7) Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 6 | Common | Common Stock | 2022-02-15 | S | D | 185 | $631.67 | 59,138 | D | — | — | (F8) Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-02-15 | S | D | 289 | $632.71 | 58,849 | D | — | — | (F9) Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-02-15 | S | D | 220 | $633.54 | 58,629 | D | — | — | (F10) Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 9 | Common | Common Stock | 2022-02-15 | S | D | 159 | $634.43 | 58,470 | D | — | — | (F11) Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-02-15 | S | D | 50 | $625.90 | 61,861 | D | — | — | |
| 11 | Common | Common Stock | 2022-02-15 | S | D | 99 | $622.09 | 61,911 | D | — | — | (F2) Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price. |
| 12 | Common | Common Stock | 2022-02-14 | M | A | 10,000 | $179.13 | 68,470 | D | — | — | |
| 13 | Common | Common Stock | 2022-02-14 | F | D | 6,460 | $626.79 | 62,010 | D | — | — | |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-02-14 | M | D | 10,000 | $0.00 | 30,000 | D | $179.13 · — to 2022-12-14 | 10,000 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |